Operating income decreased 90.8%
Operating income changed -90.8% from the comparable as-filed period.
-$6.0M→-$11.5M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MDCX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 27.7%
Operating cash flow changed -27.7% from the comparable as-filed period.
-$5.5M→-$7.0M3 prior comparisons
Shares outstanding increased 254.6%
Shares outstanding changed +254.6% from the comparable as-filed period.
17,816,266→63,180,6103 prior comparisons
Research & development increased 240.9%
Research & development changed +240.9% from the comparable as-filed period.
$1.4M→$4.9M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.